ondasdechoque.org
PT-BR
A patient guide to the research

Shockwave research, explained

Explore analyses based on verified full-text sources. Abstract-only and partial readings are not shown as analyses.

137full-text analyses
44randomized trials
59systematic syntheses
1996–2026publication years
Scroll to explore the research ↓

Research reports

137 of 137 reports

Explore collection statistics

Counts describe publications. Participant totals are not added across reports.

Reports by publication year

  1. 202631
  2. 202523
  3. 202418
  4. 202315
  5. 20227
  6. 20212
  7. 20202
  8. 20193
  9. 20182
  10. 20174
  11. 20161
  12. 20153
  13. 20142
  14. 20132
  15. 20123
  16. 20112
  17. 20103
  18. 20094
  19. 20082
  20. 20072
  21. 20041
  22. 20032
  23. 20021
  24. 20011
  25. 19961

Reports by publication type

  1. Systematic review with meta-analysis21
  2. Randomized comparative clinical trial14
  3. Systematic review with network meta-analysis11
  4. Randomized trials7
  5. Systematic clinical review6
  6. Randomized trial with sham / placebo control5
  7. clinical synthesis4
  8. nonrandom comparative4
  9. Randomized treatment-schedule comparison3
  10. Umbrella review3
  11. Uncontrolled studies3
  12. mixed translational2
  13. Nonrandomized comparative study2
  14. Randomized adjunct-treatment trial2
  15. randomized trial2
  16. Randomized trial2
  17. Retrospective treated-cohort prognostic study2
  18. Clinical guideline supported by an evidence review1
  19. Comparative evidence synthesis with meta-analysis1
  20. Controlled laboratory animal experiment with 36 male Sprague Dawley rats divided equally among three groups. Random allocation and blinded outcome assessment are not clearly described. No human patients were enrolled.1
  21. Exploratory secondary analysis of a feasibility trial1
  22. Letter to the editor1
  23. Meta-analysis of long-term comparative trials1
  24. Mixed clinical / preclinical1
  25. Multiple single-case experiments with randomized baseline length1
  26. Narrative management review with selected randomized trials organized by indication. It is not a new trial or a systematic meta-analysis, and no reproducible search or formal certainty grading is supplied.1
  27. Narrative mechanistic review combining cell studies, animal experiments, human anatomical/experimental pain studies and selected clinical reports. It presents no systematic search, pooled efficacy estimate or new controlled experiment.1
  28. Narrative practice review1
  29. Narrative review1
  30. Narrative review and clinical commentary1
  31. Narrative review of shockwave technology, experimental mechanisms and selected clinical studies. No reproducible systematic search, pooled analysis or formal risk-of-bias assessment is presented.1
  32. Narrative technology review with a systematic clinical component1
  33. Nonrandomized comparisons1
  34. Pooled secondary analysis of randomized-trial datasets1
  35. Post hoc analysis of a randomized trial1
  36. PRISMA-ScR scoping review of English-language human interventional and observational studies in PubMed through December 2021. Nineteen studies were included from 76 search records; no pooled effect or formal certainty assessment is supplied.1
  37. Prospective randomized comparative study. Forty-six patients were allocated; six with missing assessments were excluded and 40 were analyzed. The random sequence, allocation concealment and assessor masking are not described.1
  38. Prospective randomized patient-blinded pilot trial in Poland; computer-generated allocation and coded statistical analysis. Forty of 52 screened patients entered, 20 per group; control follow-up declined to 19 at one month and 17 at three months.1
  39. Randomized feasibility trial1
  40. Randomized pilot trial with random-number block allocation and opaque envelopes; patients and follow-up assessors were blinded. Thirty participants were analyzed. The flow describes 37 assessed, six declining after symptom relief and one follow-up loss.1
  41. Randomized sham-controlled trial; per-protocol primary analysis1
  42. Randomized trial with acute mechanistic outcomes1
  43. Randomized trial with later elective crossover1
  44. Retrospective nonrandomized treatment comparison1
  45. Retrospective single-cohort before-after study1
  46. Scoping / narrative review1
  47. Scoping review of primary studies harvested from seven existing reviews/meta-analyses identified through PubMed, PEDro and Cochrane to August 2025. Of 83 extracted records, 48 duplicates were removed and 35 articles analyzed. This is a methodological audit, not a new efficacy meta-analysis.1
  48. Secondary individual-participant analysis of active-treatment arms1
  49. Secondary trajectory analysis of a randomized trial1
  50. Single-arm intervention and prediction-model study1
  51. Single-blind prospective randomized trial, computer-generated allocation in sealed packets. Forty-five participants were randomized equally; 41 completed and were analyzed: 13 control, 13 shockwave, 15 combined. Masking of subjective treatment experiences was not feasible.1
  52. Single-centre observational proof-of-concept diagnostic study, without blinded comparison, independent reference standard or treatment efficacy follow-up.1
  53. Single-centre randomized, assessor-blinded, sham-controlled trial, registered NCT02221011. An independent researcher used computer-generated block allocation, 1:1:1; 60 participants completed follow-up.1
  54. Systematic mechanistic review with human, animal and laboratory components1
  55. Systematic review and random-effects meta-analysis of 10 randomized trials, searched through 30 April 2021 across databases, registries and grey literature; protocol CRD 42021250013. Risk of bias, Jadad and GRADE assessments were used.1
  56. Systematic review combining primary studies and reviews1
  57. Systematic review of human and preclinical studies1
  58. Systematic review with before-after meta-analysis1
  59. Systematic review with meta-analysis of controlled clinical studies, searching four databases to October 2021 in English. Nonrandomized and allocation-unclear studies were eligible. The abstract says eight studies, whereas the flowchart, Table 1 and Discussion identify ten.1
  60. uncontrolled clinical1
  61. Uncontrolled repeated-measures clinical study1